Wells Fargo & Company Fulgent Genetics, Inc. Transaction History

Wells Fargo & Company

  • $433 Billion
  • Q4 2024

A detailed history of Wells Fargo & Company transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 14,010 shares of FLGT stock, worth $227,242. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,010
Previous 1,000,000 98.6%
Holding current value
$227,242
Previous $21.7 Million 98.81%
% of portfolio
0.0%
Previous 0.01%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025
BUY
$16.71 - $22.68 $41,591 - $56,450
2,489 Added 21.6%
14,010 $258,000
Q3 2024

Nov 13, 2024
BUY
$19.6 - $25.06 $12,348 - $15,787
630 Added 5.78%
11,521 $250,000
Q2 2024

Aug 13, 2024
BUY
$19.09 - $22.57 $11,415 - $13,496
598 Added 5.81%
10,891 $213,000
Q1 2024

May 10, 2024
BUY
$21.55 - $29.29 $6,508 - $8,845
302 Added 3.02%
10,293 $223,000
Q4 2023

Feb 09, 2024
BUY
$23.64 - $30.27 $26,713 - $34,205
1,130 Added 12.75%
9,991 $288,000
Q3 2023

Nov 13, 2023
SELL
$26.74 - $40.81 $116,880 - $178,380
-4,371 Reduced 33.03%
8,861 $236,000
Q2 2023

Aug 15, 2023
BUY
$28.52 - $40.7 $111,056 - $158,485
3,894 Added 41.7%
13,232 $489,000
Q1 2023

May 12, 2023
BUY
$29.39 - $36.27 $96,487 - $119,074
3,283 Added 54.22%
9,338 $291,000
Q4 2022

Feb 13, 2023
SELL
$29.23 - $40.28 $10,084 - $13,896
-345 Reduced 5.39%
6,055 $180,000
Q3 2022

Nov 14, 2022
SELL
$37.92 - $63.74 $282,769 - $475,309
-7,457 Reduced 53.81%
6,400 $244,000
Q2 2022

Aug 12, 2022
SELL
$47.98 - $62.75 $947,365 - $1.24 Million
-19,745 Reduced 58.76%
13,857 $755,000
Q1 2022

May 16, 2022
SELL
$49.85 - $96.11 $1.43 Million - $2.76 Million
-28,722 Reduced 46.08%
33,602 $2.1 Million
Q4 2021

Feb 14, 2022
BUY
$77.3 - $105.0 $732,958 - $995,610
9,482 Added 17.94%
62,324 $6.27 Million
Q3 2021

Nov 15, 2021
SELL
$74.87 - $110.87 $392,393 - $581,069
-5,241 Reduced 9.02%
52,842 $4.75 Million
Q2 2021

Aug 16, 2021
SELL
$66.8 - $100.45 $380,158 - $571,660
-5,691 Reduced 8.92%
58,083 $5.36 Million
Q1 2021

May 13, 2021
BUY
$59.3 - $183.85 $383,374 - $1.19 Million
6,465 Added 11.28%
63,774 $6.16 Million
Q4 2020

Feb 09, 2021
BUY
$31.01 - $52.1 $163,639 - $274,931
5,277 Added 10.14%
57,309 $2.99 Million
Q3 2020

Nov 05, 2020
BUY
$15.89 - $50.51 $447,780 - $1.42 Million
28,180 Added 118.15%
52,032 $2.08 Million
Q2 2020

Aug 13, 2020
BUY
$8.89 - $18.28 $128,931 - $265,114
14,503 Added 155.13%
23,852 $382,000
Q1 2020

May 14, 2020
BUY
$6.75 - $19.75 $63,105 - $184,642
9,349 New
9,349 $100,000

Others Institutions Holding FLGT

# of Institutions
206
Shares Held
16.6M
Call Options Held
2.04M
Put Options Held
14K
View Full List

About Fulgent Genetics, Inc.

FLGT Quotes by TradingView
  • Ticker FLGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,265,800
  • Market Cap $491M
  • Description
  • Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...
More about FLGT
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email